Snowden Capital Advisors LLC Charles River Laboratories International, Inc. Transaction History

Snowden Capital Advisors LLC

$3.02 Billion
Q1 2025

A detailed history of Snowden Capital Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 1,582 shares of CRL stock, worth $214,566. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,582

Previous 2,459 35.66%

Holding current value

$214,566

Previous $453,000 47.46%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$150.52 - $190.14 $132,006 - $166,752	-877 Reduced 35.66%	1,582 $238,000
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $72,503 - $89,600	-406 Reduced 14.17%	2,459 $453,000
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $179,313 - $234,006	954 Added 49.92%	2,865 $564,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $42,103 - $54,820	-204 Reduced 9.65%	1,911 $394,000
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $44,570 - $59,881	-219 Reduced 9.38%	2,115 $573,000
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $35,865 - $52,067	218 Added 10.3%	2,334 $551,000
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $32,860 - $36,776	-169 Reduced 7.4%	2,116 $414,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $71,830 - $82,207	391 Added 20.64%	2,285 $480,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $45,861 - $62,120	239 Added 14.44%	1,894 $382,000
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $36,859 - $46,763	-187 Reduced 10.15%	1,655 $360,000
Q3 2022 Nov 09, 2022	BUY	$182.44 - $250.54 $24,811 - $34,073	136 Added 7.97%	1,842 $362,000
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $146,361 - $216,820	-717 Reduced 29.59%	1,706 $365,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $526,861 - $746,670	2,062 Added 571.19%	2,423 $688,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $126,848 - $161,973	361 New	361 $136,000
Q3 2021 Feb 05, 2024	SELL	$372.64 - $458.3 $50,679 - $62,328	-136 Reduced 6.43%	1,980 $817 Million
Q2 2021 Jan 08, 2024	BUY	$294.17 - $371.65 $530,094 - $669,713	1,802 New	1,802 $667 Million
Q1 2020 Jan 08, 2024	SELL	$98.9 - $178.34 $4.16 Million - $7.51 Million	-42,100 Closed	0 $0
Q4 2019 Jan 08, 2024	BUY	$126.05 - $152.76 $592,435 - $717,972	4,700 Added 12.57%	42,100 $64.3 Million
Q3 2019 Jan 08, 2024	BUY	$125.07 - $143.67 $4.41 Million - $5.07 Million	35,284 Added 1667.49%	37,400 $49.5 Million

Others Institutions Holding CRL

# of Institutions

649

Shares Held

55M

Call Options Held

695K

Put Options Held

809K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $6.9B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Charles River Laboratories International, Inc. Transaction History